Duane B. Lakings, Ph.D.
Specialties: R&D, Regulatory
Biography
Duane B. Lakings, Ph.D., is the Principal and President of Drug Safety Evaluation Consulting, Inc. DSE Consulting assists pharmaceutical and biotechnology companies in designing, conducting, and interpreting results from experiments for characterizing and developing drug candidates into therapeutic products. Dr. Lakings has over 45 years of experience in drug discovery and developability assessment, preclinical and nonclinical development, and clinical development and has designed and conducted animal and human research studies on both small organic molecules and macromolecules.
His primary areas of expertise include pharmacokinetics and toxicokinetics, drug metabolism and ADME, drug delivery, and bioanalytical chemistry and he has excellent knowledge of the pharmacology, toxicology, and clinical requirement for successful drug development. During his career, he has been involved in characterizing drug candidates for a number of therapeutic diseases and disorders, including CNS, cardiovascular, metabolic diseases, oncology, infectious diseases (bacterial and viral), and dermatology. Since opening DSE Consulting, he has used his knowledge to assist clients with defining drug development logic plans, selecting and managing CROs, and preparing study reports for completed nonclinical and clinical research studies.